Canadian CANNAINVESTOR Magazine August / September 2017 - Page 209

199

We have been proponents of investing in hemp companies for well over a year and a recent article suggests that just may be a good strategy. If you have not looked at adding a company in the hemp sector to your portfolio or watch list, it may be a good time to do due diligence and revisit that decision.

HEMPCO is a company with solid revenues and may be a part of the consolidation process and Ecoforming – events that are unfolding before our eyes rather than after the fact such as when an acquisition is announced. The ACB investment into HEMPCO may be of particular interest because Industrial Hemp may be able to add to the ACB line of CBD offerings and in fact this aspect is built into their agreement as Aurora has first right of refusal for HEMPCO’s Industrial Hemp if CBD extraction from hemp is legalized – that is but one example. That possibility was something I realized as soon as ACB’s strategic investment was announced. As we mentioned over a year ago using Mettrum Inc as our example, a HEMP line allows marketing and advertising channels not permitted in the marijuana industry as well as market access to a wider spectrum of consumers (hemp products).

ACB’s strategic investment into a hemp company was to be expected. What is intriguing is that in time one may see the ACB ownership stake increase potentially to the benefit of HEMPCO shareholders. Regardless, this partial integration may add new revenue streams and markets for HEMPCO and also for ACB.

As an aside, True Leaf Medicine Inc (CSE:MJ; OTC:TRLFF) has been referenced not only for those interested in a late stage ACMPR applicant and a leading company in the animal care sector but also for the hemp sector (animal care specifically).

ISODIOL INTERNATIONAL INC (CSE:ISOL; OTC:ISOLF; FRA:LB6A)

Investing.com August 4 sentiment: BUY

There is not much to add to this company that our subscribers have not been alerted to for several months and our subscribers that invested at share prices below $0.15 have been rewarded nicely. Recent highlights include:

- Record quarterly revenue including positive profits announced. SOURCE

- July sales numbers were released and suggest the potential for another record breaking quarterly revenue is on track.

- Signs definitive licensing agreement with Canopy Growth Corporation for Canadian and International distribution. SOURCE